BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14569444)

  • 1. Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
    Ikeda K; Arase Y; Kobayashi M; Saitoh S; Someya T; Hosaka T; Suzuki Y; Suzuki F; Tsubota A; Akuta N; Kumada H
    J Gastroenterol; 2003; 38(9):865-76. PubMed ID: 14569444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
    J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
    Ikeda K; Saitoh S; Koida I; Arase Y; Tsubota A; Chayama K; Kumada H; Kawanishi M
    Hepatology; 1993 Jul; 18(1):47-53. PubMed ID: 7686879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.
    Kawamura Y; Ikeda K; Arase Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1739-46. PubMed ID: 18713301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Uenishi T; Nishiguchi S; Tanaka S; Yamamoto T; Takemura S; Kubo S
    J Surg Oncol; 2008 Oct; 98(5):358-62. PubMed ID: 18646001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
    Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts.
    Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Akuta N; Suzuki Y; Suzuki F; Sezaki H; Kumada H; Tanaka A; Harada H
    J Hepatol; 2006 Jun; 44(6):1089-97. PubMed ID: 16618514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy.
    Shimada K; Sano T; Sakamoto Y; Kosuge T
    Cancer; 2005 Nov; 104(9):1939-47. PubMed ID: 16177997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
    Arata S; Tanaka K; Okazaki H; Kondo M; Morimoto M; Saito S; Numata K; Nakamura S; Sekihara H
    Hepatogastroenterology; 2001; 48(38):480-5. PubMed ID: 11379338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
    Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.